Best in Class Anti-Infectives
November 6, 2009
Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
September 12, 2009
Trius' Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
July / August, 2009
PharmaVOICE selects Dr. Jeff Stein as one of their 100 of the Most Inspiring People.
June 8, 2009
April 20, 2009
Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board
Most Successful
U.S. Startups 2008
October 22, 2008
Trius Awarded $28 Million Contract to Develop Novel Antibiotics